MFI 14 52.67 (Money returning into stock and above 50). MACD cross above trigger line (Look at the last time the MACD crossed at this level). RSI 14 50.36 (Bullish 50 line crossover). Within Upper BB with support from 2.78 - 2.69. Pullback today after several up days. Still within trend line. Possible FDA ANPRM issued next week on mandates on nicotine levels in...
XXII Reversal trend. Back within trend line. MFI 10 above 50. RSI 14 above 50. MACD cross over trigger line. Potential FDA ANPRM released in several days in regards to lower nicotine levels in US Tobacco.
Potential reversal for XXII. MACD closer to trigger line and curl up. A lot of potential with XXII and looks as if this could be a reversal bounce off 200 SMA.
Great opportunity with 22nd Century Group. Potential reversal bounce off 200 SMA and positive divergence on MFI 14. Many things in the works right now with XXII. Phase 3 peer review soon, ANRPN from FDA on VLN tobacco, and increased institutional investment in Q4 2017.
